Article
Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society - 1 Jul 2004
Stravitz R Todd, Shiffman Mitchell L, Sanyal Arun J, Luketic Velimir A, Sterling Richard K, Heuman Douglas M, Ashworth April, Mills A Scott, Contos Melissa, Cotterell Adrian H, Maluf Daniel, Posner Marc P, Fisher Robert A
Abstract excerpt
Recurrent hepatitis C after liver transplantation remains a significant cause of graft loss and retransplantation. Although treatment of recurrent hepatitis C with interferon-based regimens has become widely accepted as safe and can lead to sustained virologic clearance of hepatitis C virus (HCV) RNA, long-term histologic improvement and the risk of precipitating graft rejection remain controversial. The present...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.